Refine
Year of publication
Document Type
- Article (128)
- Preprint (41)
- Conference Proceeding (2)
- Book (1)
- Contribution to a Periodical (1)
- Working Paper (1)
Has Fulltext
- yes (174)
Is part of the Bibliography
- no (174)
Keywords
- Mammakarzinom (10)
- breast cancer (10)
- Behandlung (8)
- Metastasen (8)
- LHC (7)
- CDK4/6 (6)
- PD1/PDL1 (6)
- Prävention (6)
- Studien (6)
- prevention (6)
- treatment (6)
- metastases (5)
- Risiko (4)
- risk (4)
- trials (4)
- ALICE experiment (3)
- Hadron-Hadron Scattering (3)
- Penile carcinomas (3)
- metastatic (3)
- pp collisions (3)
- ALICE (2)
- Alpelisib (2)
- Atezolizumab (2)
- Beauty production (2)
- Clinical Trials and Observations (2)
- Heavy Ions (2)
- Heavy-ion collisions (2)
- Katherine (2)
- Lokalrezidiv (2)
- PARP (2)
- PD1/ PDL1 (2)
- PD‑L1 (2)
- PI3K (2)
- Prognosefaktoren (2)
- Prädiktivfaktoren (2)
- Single electrons (2)
- Supportivtherapie (2)
- Tumor microenvironment (2)
- T‑DM1 (2)
- Viral infection (2)
- adjuvant therapy (2)
- adjuvante Therapie (2)
- advanced (2)
- alpelisib (2)
- atezolizumab (2)
- early breast cancer (2)
- fortgeschritten (2)
- frühes Mammakarzinom (2)
- local recurrence (2)
- neoadjuvant therapy (2)
- neoadjuvante Therapie (2)
- predictive factors (2)
- prognostic factors (2)
- studies (2)
- supportive therapy (2)
- treatment/therapy (2)
- ALICE LHC (1)
- Acetogenesis (1)
- Advanced breast cancer (1)
- Aging (1)
- Antibodies (1)
- Antihormone therapy (1)
- Antirheumatic agents (1)
- Artificial Intelligence (1)
- BCL2 (1)
- BCOR (1)
- BCORL1 (1)
- Balance function (1)
- Bioenergetics (1)
- Body Composition (1)
- Brain metastasis (1)
- CD74 (1)
- CVID (1)
- Calorimeters (1)
- Carbonate geochemistry (1)
- Care home (1)
- Charge correlations (1)
- Charged-particle density (1)
- Charm physics (1)
- Child (1)
- Cognitive behavioural therapy (1)
- Comparative effectiveness research (1)
- Comparison with QCD (1)
- Consensus (1)
- DTHR (1)
- Dermatomyositis (1)
- Diagenesis (1)
- Diagnosis (1)
- Dolomite (1)
- Dolomitisation (1)
- D’Amico classification (1)
- EBV (1)
- Electron Bifurcation (1)
- Electron Transfer (1)
- Energy Conservation (1)
- Enzyme Mechanisms (1)
- European Society for Immunodeficiencies (ESID) (1)
- FDG-PET/CT (1)
- Femtoscopy (1)
- Genetics (1)
- Genome-wide association studies (1)
- German PID-NET registry (1)
- Gleason score (1)
- HBT (1)
- HER2 c-erbB2 (1)
- HER2/neu (1)
- HLA class II (1)
- HLA peptidome (1)
- HNSCC (1)
- HPV infection (1)
- Hadron production (1)
- Head neck cancer (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour production (1)
- HepG2 (1)
- Hepatocellular Carcinoma (1)
- Heregulin (1)
- Huh7 (1)
- Hygroscopicity (1)
- IgG substitution therapy (1)
- Immunotherapy (1)
- Inclusive spectra (1)
- Induction therapy (1)
- Intensity interferometry (1)
- Irisch (1)
- Iron-Sulfur Protein (1)
- Jets (1)
- Karstification (1)
- Kette <Linguistik> (1)
- Komplementierer (1)
- LCD-Array (1)
- LTER (1)
- Large Hadron Collider (1)
- Long‐term ecosystem research (1)
- Lymphoid Neoplasia (1)
- MM-121 (1)
- MYC (1)
- Metalloenzymes (1)
- Metastatic (1)
- Mid-rapidity (1)
- Migration (1)
- Monte Carlo (1)
- Multi-strange baryons (1)
- Myeloid Neoplasia (1)
- NASH (1)
- NEAT1 (1)
- NETs (1)
- Neutrophils (1)
- Nuclear modification factor (1)
- Older adult (1)
- Organosulfates (1)
- PD-L1 (1)
- PID prevalence (1)
- Paediatrics (1)
- Paleothermometry (1)
- Pb–Pb (1)
- Performance of High Energy Physics Detectors (1)
- Pronomen (1)
- Proton–proton (1)
- Proxy record (1)
- ROS/RNS (1)
- Relativistic heavy ion physics (1)
- Research infrastructure (1)
- Rock archive (1)
- SARS-CoV-2 (1)
- SELEX (1)
- SOA (1)
- Sanger Sequencing (1)
- Screening (1)
- Seribantumab (1)
- Single muons (1)
- Site networks (1)
- Stem-cell therapies (1)
- Stigma (1)
- Survival (1)
- Systematic Uncertainty (1)
- T-DM1 (1)
- Time Projection Chamber (1)
- Tissue microarray (1)
- Transarterial Chemoembolization (1)
- Transverse Momentum (1)
- Tumor infiltrating lymphocytes (1)
- U-Pb dating (1)
- Urological oncology (1)
- VEGFA (1)
- Viral oncology (1)
- Wide rapidity coverage (1)
- activated factor XIII (1)
- acute chronic inflammation (1)
- acute myeloid leukemia (1)
- advanced breast cancer (1)
- antibiotic therapy (1)
- antibodies (1)
- antihormone therapy (1)
- aptamer (1)
- aptamer modeling (1)
- ascites (1)
- austerity (1)
- autoantibodies (1)
- b-cell lymphomas (1)
- bendamustine (1)
- chemoresistance (1)
- chemotherapy (1)
- chemotherapy regimen (1)
- chimeric antigen receptor t-cell therapy (1)
- chimeric antigen receptors (1)
- confidence (1)
- congruency (1)
- cortex (1)
- cross-modal (1)
- diffusion-weighted magnetic resonance imaging (1)
- fiscal policy (1)
- fiscal stress (1)
- flow cytometry (1)
- functional magnetic resonance imaging (1)
- hematopoietic stem cell transplantation (1)
- human (1)
- inverse stage migration (1)
- lapatinib (1)
- leukapheresis (1)
- liver cancer (1)
- liver cirrhosis (1)
- local projections (1)
- loss-of-function (1)
- lymphoma (1)
- metastasis (1)
- multidrug resistance (1)
- multiplexed immunofluorescence (1)
- multisensory (1)
- neoadjuvant chemoradiotherapy (1)
- nucleic acid docking (1)
- object perception (1)
- oral cavity cancer (1)
- p16 (1)
- panel VAR (1)
- pertuzumab (1)
- predictive biomarker (1)
- primary biliary cholangitis (1)
- primary immunodeficiency (PID) (1)
- prostate cancer (1)
- radical prostatecomy (1)
- registry for primary immunodeficiency (1)
- risk stratification (1)
- rituximab (1)
- screening routine (1)
- second line therapy (1)
- sovereign risk (1)
- spectra (1)
- survival (1)
- transglutaminase (1)
- trastuzumab (1)
- treatment response (1)
- ursodeoxycholic acid (1)
- yield spreads (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (112)
- Frankfurt Institute for Advanced Studies (FIAS) (100)
- Informatik (99)
- Medizin (47)
- Geowissenschaften (4)
- Biowissenschaften (3)
- Biochemie und Chemie (1)
- Center for Financial Studies (CFS) (1)
- Erziehungswissenschaften (1)
- House of Finance (HoF) (1)
Synthesis of acetate from carbon dioxide and molecular hydrogen is considered to be the first carbon assimilation pathway on earth. It combines carbon dioxide fixation into acetyl-CoA with the production of ATP via an energized cell membrane. How the pathway is coupled with the net synthesis of ATP has been an enigma. The anaerobic, acetogenic bacterium Acetobacterium woodii uses an ancient version of this pathway without cytochromes and quinones. It generates a sodium ion potential across the cell membrane by the sodium-motive ferredoxin:NAD oxidoreductase (Rnf). The genome sequence of A. woodii solves the enigma: it uncovers Rnf as the only ion-motive enzyme coupled to the pathway and unravels a metabolism designed to produce reduced ferredoxin and overcome energetic barriers by virtue of electron-bifurcating, soluble enzymes.
Background: Nitric oxide (NO) is an essential vasodilator. In vascular diseases, oxidative stress attenuates NO signaling by both chemical scavenging of free NO and oxidation and down-regulation of its major intracellular receptor, the alpha/beta heterodimeric heme-containing soluble guanylate cyclase (sGC). Oxidation can also induce loss of sGC's heme and responsiveness to NO.
Results: sGC activators such as BAY 58-2667 bind to oxidized/heme-free sGC and reactivate the enzyme to exert disease-specific vasodilation. Here we show that oxidation-induced down-regulation of sGC protein extends to isolated blood vessels. Mechanistically, degradation was triggered through sGC ubiquitination and proteasomal degradation. The heme-binding site ligand, BAY 58-2667, prevented sGC ubiquitination and stabilized both alpha and beta subunits.
Conclusion: Collectively, our data establish oxidation-ubiquitination of sGC as a modulator of NO/cGMP signaling and point to a new mechanism of action for sGC activating vasodilators by stabilizing their receptor, oxidized/heme-free sGC.
Penile squamous cell carcinomas are rare tumor entities throughout Europe. Early lymphonodal spread urges for aggressive therapeutic approaches in advanced tumor stages. Therefore, understanding tumor biology and its microenvironment and correlation with known survival data is of substantial interest in order to establish treatment strategies adapted to the individual patient. Fifty-five therapy naïve squamous cell carcinomas, age range between 41 and 85 years with known clinicopathological data, were investigated with the use of tissue microarrays (TMA) regarding the tumor-associated immune cell infiltrate density (ICID). Slides were stained with antibodies against CD3, CD8 and CD20. An image analysis software was applied for evaluation. Data were correlated with clinicopathological characteristics and overall survival. There was a significant increase of ICID in squamous cell carcinomas of the penis in relation to tumor adjacent physiological tissue. Higher CD3-positive ICID was significantly associated with lower tumor stage in our cohort. The ICID was not associated with overall survival. Our data sharpens the view on tumor-associated immune cell infiltrate in penile squamous cell carcinomas with an unbiased digital and automated cell count. Further investigations on the immune cell infiltrate and its prognostic and possible therapeutic impact are needed.
Background In melanoma, preclinical data suggest a possible role of polyunsaturated fatty acids inhibiting cell growth. A new target molecule for free fatty acids, the G protein-coupled receptor GPR40, was identified in melanoma cells.
Objectives The aim of this study was to investigate GPR40 expression in human melanocytic tissues and to evaluate its potential as a prognostic marker.
Methods and Results A total of 114 tissue sections of naevi, primary melanoma and melanoma metastasis were immunohistochemically stained with anti-GPR40. The staining was evaluated, using the immunoreactivity scoring system. Compared to naevi, primary melanoma and melanoma metastasis showed significantly higher levels of GPR40 (P < 0.05). In primary melanoma, GPR40 expression positively correlated with tumour thickness (P = 0.044) and AJCC level (P = 0.017) and in melanoma metastasis with AJCC level (P = 0.035). Primary melanoma patients with high levels of GPR40 had a significantly poorer overall survival (P = 0.004) and shorter disease-free survival (0.040).
Conclusion The present study identified GPR40 as a novel target molecule in melanoma. First evidence for a potential role of the receptor in tumour progression and metastases was found, and it could be demonstrated that GPR40 expression is negatively correlated with patient’s survival.
Three neonicotinoids, imidacloprid, clothianidin and thiacloprid, agonists of the nicotinic acetylcholine receptor in the central brain of insects, were applied at non-lethal doses in order to test their effects on honeybee navigation. A catch-and-release experimental design was applied in which feeder trained bees were caught when arriving at the feeder, treated with one of the neonicotinoids, and released 1.5 hours later at a remote site. The flight paths of individual bees were tracked with harmonic radar. The initial flight phase controlled by the recently acquired navigation memory (vector memory) was less compromised than the second phase that leads the animal back to the hive (homing flight). The rate of successful return was significantly lower in treated bees, the probability of a correct turn at a salient landscape structure was reduced, and less directed flights during homing flights were performed. Since the homing phase in catch-and-release experiments documents the ability of a foraging honeybee to activate a remote memory acquired during its exploratory orientation flights, we conclude that non-lethal doses of the three neonicotinoids tested either block the retrieval of exploratory navigation memory or alter this form of navigation memory. These findings are discussed in the context of the application of neonicotinoids in plant protection.
Since the domestication of the urus, 10.000 years ago, mankind utilizes bovine milk for different purposes. Besides usage as a nutrient also the external application of milk on skin has a long tradition going back to at least the ancient Aegypt with Cleopatra VII as a great exponent. In order to test whether milk has impact on skin physiology, cultures of human skin fibroblasts were exposed to commercial bovine milk. Our data show significant induction of proliferation by milk (max. 2,3-fold, EC50: 2,5% milk) without toxic effects. Surprisingly, bovine milk was identified as strong inducer of collagen 1A1 synthesis at both, the protein (4-fold, EC50: 0,09% milk) and promoter level. Regarding the underlying molecular pathways, we show functional activation of STAT6 in a p44/42 and p38-dependent manner. More upstream, we identified IGF-1 and insulin as key factors responsible for milk-induced collagen synthesis. These findings show that bovine milk contains bioactive molecules that act on human skin cells. Therefore, it is tempting to test the herein introduced concept in treatment of atrophic skin conditions induced e.g. by UV light or corticosteroids.
Background and Aims: The prevalence of hepatitis C virus (HCV) antibodies in Germany has been estimated to be in the range of 0.4–0.63%. Screening for HCV is recommended in patients with elevated ALT levels or significant risk factors for HCV transmission only. However, 15–30% of patients report no risk factors and ALT levels can be normal in up to 20–30% of patients with chronic HCV infection. The aim of this study was to assess the HCV seroprevalence in patients visiting two tertiary care emergency departments in Berlin and Frankfurt, respectively.
Methods: Between May 2008 and March 2010, a total of 28,809 consecutive patients were screened for the presence of anti-HCV antibodies. Anti-HCV positive sera were subsequently tested for HCV-RNA.
Results: The overall HCV seroprevalence was 2.6% (95% CI: 2.4–2.8; 2.4% in Berlin and 3.5% in Frankfurt). HCV-RNA was detectable in 68% of anti-HCV positive cases. Thus, the prevalence of chronic HCV infection in the overall study population was 1.6% (95% CI 1.5–1.8). The most commonly reported risk factor was former/current injection drug use (IDU; 31.2%) and those with IDU as the main risk factor were significantly younger than patients without IDU (p<0.001) and the male-to-female ratio was 72% (121 vs. 46 patients; p<0.001). Finally, 18.8% of contacted HCV-RNA positive patients had not been diagnosed previously.
Conclusions: The HCV seroprevalence was more than four times higher compared to current estimates and almost one fifth of contacted HCV-RNA positive patients had not been diagnosed previously.
This paper reports on Monte Carlo simulation results for future measurements of the moduli of time-like proton electromagnetic form factors, |GE | and |GM|, using the ¯pp → μ+μ− reaction at PANDA (FAIR). The electromagnetic form factors are fundamental quantities parameterizing the electric and magnetic structure of hadrons. This work estimates the statistical and total accuracy with which the form factors can be measured at PANDA, using an analysis of simulated data within the PandaRoot software framework. The most crucial background channel is ¯pp → π+π−,due to the very similar behavior of muons and pions in the detector. The suppression factors are evaluated for this and all other relevant background channels at different values of antiproton beam momentum. The signal/background separation is based on a multivariate analysis, using the Boosted Decision Trees method. An expected background subtraction is included in this study, based on realistic angular distribuations of the background contribution. Systematic uncertainties are considered and the relative total uncertainties of the form factor measurements are presented.
Bipolar disorder (BD) is a highly heritable neuropsychiatric disease characterized by recurrent episodes of mania and depression. BD shows substantial clinical and genetic overlap with other psychiatric disorders, in particular schizophrenia (SCZ). The genes underlying this etiological overlap remain largely unknown. A recent SCZ genome wide association study (GWAS) by the Psychiatric Genomics Consortium identified 128 independent genome-wide significant single nucleotide polymorphisms (SNPs). The present study investigated whether these SCZ-associated SNPs also contribute to BD development through the performance of association testing in a large BD GWAS dataset (9747 patients, 14278 controls). After re-imputation and correction for sample overlap, 22 of 107 investigated SCZ SNPs showed nominal association with BD. The number of shared SCZ-BD SNPs was significantly higher than expected (p = 1.46x10-8). This provides further evidence that SCZ-associated loci contribute to the development of BD. Two SNPs remained significant after Bonferroni correction. The most strongly associated SNP was located near TRANK1, which is a reported genome-wide significant risk gene for BD. Pathway analyses for all shared SCZ-BD SNPs revealed 25 nominally enriched gene-sets, which showed partial overlap in terms of the underlying genes. The enriched gene-sets included calcium- and glutamate signaling, neuropathic pain signaling in dorsal horn neurons, and calmodulin binding. The present data provide further insights into shared risk loci and disease-associated pathways for BD and SCZ. This may suggest new research directions for the treatment and prevention of these two major psychiatric disorders.